AI INNOVATION CENTER AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: OR
Ove Rustung Hjelmervik1942
Chairman of the board: OR
Ove Rustung Hjelmervik1942
Years since formation: 10 years; since Aug 3, 2015
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 84,210; 1 share class
Total number of shareholders: 6; 1 company, 5 persons

Financials

Annual total result 2024: -129,959; NOK
Total equity 2024: 1,018,879; NOK

Last update: Jun 6, 2025

Management

Management / administration

Name	Role	Shares
OR Ove Rustung Hjelmervik 1942	Managing Director/CEO	42.76 % directly

Board

Name	Role	Shares
OR Ove Rustung Hjelmervik 1942	Chairman	42.76 % directly
ØK Øivind Kristoffersen 1946	Deputy Chair	19.24 % directly
TS Terje Solsvik Kristensen 1947	Board Member	31.58 % directly
RB Rune Brakstad 1952	Board Member	3 % indirectly

Others

Name	Role	Shares
T T RATIO AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
OR Ove Rustung Hjelmervik 1942	Managing Director/CEO, Chairman	42.76 % directly
TS Terje Solsvik Kristensen 1947	Board Member	31.58 % directly
ØK Øivind Kristoffersen 1946	Deputy Chair	19.24 % directly
RB Rune Brakstad 1952	Board Member	3 % indirectly
KL Kenneth Langedal 1993	-	1.07 % directly

Last update: Jun 28, 2024

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
OR Ove Rustung Hjelmervik 1942	Ordinary shares	36,010	42.76 %
TS Terje Solsvik Kristensen 1947	Ordinary shares	26,590	31.58 %
ØK Øivind Kristoffersen 1946	Ordinary shares	16,200	19.24 %
B BRAKSTAD INVEST AS	Ordinary shares	4,210	5 %
KL Kenneth Langedal 1993	Ordinary shares	900	1.07 %
ML Markus Løland 1996	Ordinary shares	300	0.36 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	0	0	0	24,675
Annual Total Result	-129,959	-35,019	-12,537	-148,838
Total assets	1,096,561	1,199,626	70,010	89,369
Total liabilities	77,682	50,788	136,153	142,975
Total equity	1,018,879	1,148,838	-66,143	-53,607

P&L

Year	2024	2023	2022	2021
Total operating income	0	0	0	24,675
Total operating costs	167,848	52,540	12,537	173,513
Operating result	-167,848	-52,540	-12,537	-148,838
Financial income/costs	37,889	17,522	0	0
Profit before tax	-129,959	-35,019	-12,537	-148,838
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-129,959	-35,019	-12,537	-148,838

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	42,750	51,300	59,850	71,372
Total current assets	1,053,811	1,148,326	10,160	17,997
Total assets	1,096,561	1,199,626	70,010	89,369
Short term debt	77,682	50,788	136,153	142,975
Long term debt	0	0	0	0
Total liabilities	77,682	50,788	136,153	142,975
Contributed capital	1,330,000	1,330,000	80,000	80,000
Retained earnings	-311,121	-181,162	-146,143	-133,607
Total equity	1,018,879	1,148,838	-66,143	-53,607
Total equity and liabilities	1,096,561	1,199,626	70,010	89,369

AI INNOVATION CENTER AS915 684 785